Breakthrough Therapy Designation
ClinicalFDA status granted to expedite development of drugs showing substantial improvement over existing treatments.
Example: Definium's LSD-derived DT120 holds this designation for generalized anxiety disorder — see our LSD patent coverage for where that program stands.
What is FDA Breakthrough Therapy Designation?
A status the FDA grants to drugs showing substantial improvement over existing treatments for a serious condition. It doesn't change the evidence bar for approval, but it gets the company more frequent FDA interaction and eligibility for a faster review.
Which psychedelic-related drug has Breakthrough Therapy Designation?
Definium's LSD-derived DT120 holds it for generalized anxiety disorder. See our LSD patent coverage for where that program stands.
Does Breakthrough status guarantee approval?
No — it's a development and review-process designation, not a pre-approval. The drug still has to complete clinical trials and go through full FDA review like any other.